Shanghai, China

Feng He

This inventor holds 82 USPTO granted patents and 63 published patent applications, plus 2 CIPO patents and 24 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D405-14). Top assignees: Zte Corporation, Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Company Ltd.. Active years: 2006-2026.

USPTO Granted Patents = 82 

% Patents Active = 70.7

 

 

Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 338(Granted Patents)

Forward Citations (Not Self Cited) = 312(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Arlington, MA (US) (2006 - 2011)
  • Cambridge, MA (US) (2012)
  • Shanhai, CN (2013)
  • Guangdong Province, CN (2014)
  • Guangdong, CN (2019)
  • Shenzhen, CN (2013 - 2020)
  • Shanghai, CN (2012 - 2024)

Company Filing History:


Years Active: 2006-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fused Imidazole Derivative
ATR Kinase Inhibitor
Human CD47 Antibody
Pyridine Derivative
Tricyclic Compound
Benzimidazole Derivative
CD73 Inhibitor
Heteroaryl Derivative
Oxopicolinamide Derivative
Pyrazolo-Heteroaryl Derivative
Five-Membered Heteroaryl
Oxa Spiro Derivative
82 patents (USPTO):Explore Patents

Hello, and welcome to idiya.com! I'm excited to share with you an article about the innovative inventor Feng He, who is making waves in the world of technology and invention. Let's delve into his remarkable journey and contributions to the field:

Title: The Visionary Innovations of Feng He: Pushing Boundaries in Technology

Introduction: Feng He, a visionary inventor based in Shanghai, China, is celebrated for his relentless pursuit of innovation and his passion for challenging the limits of what is achievable in the realm of technology and invention.

Latest Patents: With an impressive portfolio of 40 patents, Feng He continues to make significant strides in the industry. His latest patents include groundbreaking inventions such as the 'Fused Tricyclic Heterocycle Compounds' and 'Benzimidazole Derivatives as Modulators of Retinoid-Related Orphan Receptor Gamma (RORγ)'. These patents showcase his commitment to advancing pharmaceutical treatments for various diseases.

Career Highlights: Feng He has made noteworthy contributions to companies such as Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His expertise and innovative spirit have played a crucial role in the development of cutting-edge technologies within these organizations.

Collaborations: During his career, Feng He has collaborated with esteemed colleagues such as Weikang Tao and Zhuoliang Chen. Together, they have worked on pioneering projects that have pushed the boundaries of technological innovation and created new possibilities in the field.

Conclusion: In conclusion, Feng He's dedication to innovation and his visionary approach to technology have established him as a true trailblazer in the world of invention. His remarkable contributions continue to inspire and impact the industry, paving the way for a future filled with groundbreaking discoveries and advancements.

Thank you for exploring the remarkable journey of Feng He with us at idiya.com. If you have any more requests or inquiries, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…